£73.83 - £300.83 (exc VAT)
£88.60 - £361.00 (inc VAT)
A clear aqueous ready to use solution containing tulathromycin 100 mg/ml.
Cattle: Treatment and prevention of bovine respiratory disease associated with Mannheimia (Pasteurella) haemolytica, Pasteurella multocida, Mycoplasma bovis and Histophilus somni sensitive to tulathromycin. The presence of the disease in the herd should be established before preventative treatment. Treatment of infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis sensitive to tulathromycin.
Pigs: Treatment and prevention of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Mycoplasma hyopneumoniae and Haemophilus parasuis sensitive to tulathromycin. The presence of the disease in the herd should be established before preventative treatment. Draxxin should only be used if pigs are expected to develop the disease within 2-3 days.
Legal Category: POM-V
A single subcutaneous injection of 2.5 mg tulathromycin/kg body weight (equivalent to 1 ml/40 kg body weight). For treatment of cattle over 300 kg bodyweight, divide the dose so that no more than 7.5 ml are injected at one site.
A single intramuscular injection of 2.5 mg tulathromycin/kg body weight (equivalent to 1 ml/40 kg body weight) in the neck. For treatment of pigs over 80 kg bodyweight, divide the dose so that no more than 2 ml are injected at one site.
It is recommended to treat animals in the early stages of the disease and to evaluate the response to treatment within 48 hours after injection. If clinical signs of respiratory disease persist or increase, or if relapse occurs, treatment should be changed, using another antibiotic, and continued until clinical signs have resolved.
To ensure correct dosage body weight should be determined as accurately as possible to avoid underdosing.
Cattle (meat and offal): 22 days
Pigs (meat and offal): 13 days
Contra Indications: Do not use in case of hypersensitivity of the target animals to macrolide antibiotics. Do not use the product simultaneously with other macrolides or lincosamides. Do not use in lactating cattle producing milk for human consumption. Do not use in pregnant cows or heifers, which are intended to produce milk for human consumption, within 2 months of expected parturition. In the absence of compatibility studies, do not mix with other veterinary medicinal products. Subcutaneous administration of Draxxin to cattle frequently causes transient pain reactions and local swellings at the injection site that can persist for up to 30 days. No such reactions have been observed in pigs after intramuscular administration.
Package Quantities: 100ml, 50ml, 20ml
For the most up to date information about this product please look up the Summary of Product Characteristics (SPC) on the VMD webpage Product Information Database.